| 95 | | - | 59-1-1924 KR 2/21/2023 3:16:59 PM |
|---|
| 172 | + | |
|---|
| 173 | + | Req. No. 1217 Page 3 1 |
|---|
| 174 | + | 2 |
|---|
| 175 | + | 3 |
|---|
| 176 | + | 4 |
|---|
| 177 | + | 5 |
|---|
| 178 | + | 6 |
|---|
| 179 | + | 7 |
|---|
| 180 | + | 8 |
|---|
| 181 | + | 9 |
|---|
| 182 | + | 10 |
|---|
| 183 | + | 11 |
|---|
| 184 | + | 12 |
|---|
| 185 | + | 13 |
|---|
| 186 | + | 14 |
|---|
| 187 | + | 15 |
|---|
| 188 | + | 16 |
|---|
| 189 | + | 17 |
|---|
| 190 | + | 18 |
|---|
| 191 | + | 19 |
|---|
| 192 | + | 20 |
|---|
| 193 | + | 21 |
|---|
| 194 | + | 22 |
|---|
| 195 | + | 23 |
|---|
| 196 | + | 24 |
|---|
| 197 | + | 1 |
|---|
| 198 | + | 2 |
|---|
| 199 | + | 3 |
|---|
| 200 | + | 4 |
|---|
| 201 | + | 5 |
|---|
| 202 | + | 6 |
|---|
| 203 | + | 7 |
|---|
| 204 | + | 8 |
|---|
| 205 | + | 9 |
|---|
| 206 | + | 10 |
|---|
| 207 | + | 11 |
|---|
| 208 | + | 12 |
|---|
| 209 | + | 13 |
|---|
| 210 | + | 14 |
|---|
| 211 | + | 15 |
|---|
| 212 | + | 16 |
|---|
| 213 | + | 17 |
|---|
| 214 | + | 18 |
|---|
| 215 | + | 19 |
|---|
| 216 | + | 20 |
|---|
| 217 | + | 21 |
|---|
| 218 | + | 22 |
|---|
| 219 | + | 23 |
|---|
| 220 | + | 24 |
|---|
| 221 | + | |
|---|
| 222 | + | 7. “Pharmacy benefits manager” or “PBM” means a pharmacy |
|---|
| 223 | + | benefits manager as defined p ursuant to Section 6960 of Title 36 of |
|---|
| 224 | + | the Oklahoma Statues; |
|---|
| 225 | + | 8. “Reporting entity” means any manufacturer, insurer, pharmacy |
|---|
| 226 | + | benefits manager, wholesale drug distributor , or any other entity |
|---|
| 227 | + | required to report to the Insurance Department under the provisions |
|---|
| 228 | + | of this act; |
|---|
| 229 | + | 9. “Wholesale acquisition cost” means the list price of the |
|---|
| 230 | + | manufacturer charged to wholesalers or direct purchases in the |
|---|
| 231 | + | United States on December 31 of the reference year, as reported i n |
|---|
| 232 | + | the wholesale price guides or other publications of drug or |
|---|
| 233 | + | biological pricing data. This shall not include pr ompt pay or other |
|---|
| 234 | + | discounts, rebates, or reductions in price . The current or proposed |
|---|
| 235 | + | wholesale acquisition cost is the amount that requires reporting |
|---|
| 236 | + | under the provisions of this act; |
|---|
| 237 | + | 10. “Wholesale acquisition cost unit” or “WAC unit” means the |
|---|
| 238 | + | lowest identifiable quantity of a drug or biological that is |
|---|
| 239 | + | dispensed, exclusive of any diluent without reference to volume |
|---|
| 240 | + | measures pertaining to liquids. I f reporting by drug group, it is |
|---|
| 241 | + | the total number of wholesa le acquisition cost units in the drug |
|---|
| 242 | + | group; and |
|---|
| 243 | + | 11. “Wholesale drug distri butor” means a person or entity |
|---|
| 244 | + | engaging in the sale of presc ription drugs to persons o ther than a |
|---|
| 245 | + | consumer or patient and l icensed by the State Board of Pharmacy. |
|---|
| 246 | + | |
|---|
| 247 | + | |
|---|
| 248 | + | Req. No. 1217 Page 4 1 |
|---|
| 249 | + | 2 |
|---|
| 250 | + | 3 |
|---|
| 251 | + | 4 |
|---|
| 252 | + | 5 |
|---|
| 253 | + | 6 |
|---|
| 254 | + | 7 |
|---|
| 255 | + | 8 |
|---|
| 256 | + | 9 |
|---|
| 257 | + | 10 |
|---|
| 258 | + | 11 |
|---|
| 259 | + | 12 |
|---|
| 260 | + | 13 |
|---|
| 261 | + | 14 |
|---|
| 262 | + | 15 |
|---|
| 263 | + | 16 |
|---|
| 264 | + | 17 |
|---|
| 265 | + | 18 |
|---|
| 266 | + | 19 |
|---|
| 267 | + | 20 |
|---|
| 268 | + | 21 |
|---|
| 269 | + | 22 |
|---|
| 270 | + | 23 |
|---|
| 271 | + | 24 |
|---|
| 272 | + | 1 |
|---|
| 273 | + | 2 |
|---|
| 274 | + | 3 |
|---|
| 275 | + | 4 |
|---|
| 276 | + | 5 |
|---|
| 277 | + | 6 |
|---|
| 278 | + | 7 |
|---|
| 279 | + | 8 |
|---|
| 280 | + | 9 |
|---|
| 281 | + | 10 |
|---|
| 282 | + | 11 |
|---|
| 283 | + | 12 |
|---|
| 284 | + | 13 |
|---|
| 285 | + | 14 |
|---|
| 286 | + | 15 |
|---|
| 287 | + | 16 |
|---|
| 288 | + | 17 |
|---|
| 289 | + | 18 |
|---|
| 290 | + | 19 |
|---|
| 291 | + | 20 |
|---|
| 292 | + | 21 |
|---|
| 293 | + | 22 |
|---|
| 294 | + | 23 |
|---|
| 295 | + | 24 |
|---|
| 296 | + | |
|---|
| 297 | + | SECTION 2. NEW LAW A new section of law to be codified |
|---|
| 298 | + | in the Oklahoma Statutes as Section 6972 of Title 36, unless there |
|---|
| 299 | + | is created a duplication in numb ering, reads as follows: |
|---|
| 300 | + | Any pharmacy benefits manager (PBM) that operates in t his state |
|---|
| 301 | + | shall, within sixty (60) days of receiving notice by the Insurance |
|---|
| 302 | + | Department pursuant to Section 3 of this act, and to the extent |
|---|
| 303 | + | allowed by law, report annuall y to the Department, indicating the |
|---|
| 304 | + | specific drugs for which reporting is requir ed, the following |
|---|
| 305 | + | information: |
|---|
| 306 | + | 1. The minimum and maximum wholesale acquisition cost (WAC) for |
|---|
| 307 | + | each indicated drug and drug group for which the PBM has negotiated |
|---|
| 308 | + | directly with the manufacturer in the immediately p receding calendar |
|---|
| 309 | + | year; |
|---|
| 310 | + | 2. The minimum and m aximum WAC for each indicated drug and drug |
|---|
| 311 | + | group for which the PBM has negotiated directly with the |
|---|
| 312 | + | manufacturer in the current calendar year; |
|---|
| 313 | + | 3. The number of WAC unit s for which the PBM negotiated |
|---|
| 314 | + | directly with the manufacturer in the immediately prec eding calendar |
|---|
| 315 | + | year, for business in this state, in total and for e ach payer type |
|---|
| 316 | + | as deemed necessary by the Department; |
|---|
| 317 | + | 4. The projected number of WAC units for which th e PBM expects |
|---|
| 318 | + | to negotiate directly with the manufacturer in the current calendar |
|---|
| 319 | + | year, for business in this state, in total and for each payer type |
|---|
| 320 | + | as deemed necessary by the Department; |
|---|
| 321 | + | |
|---|
| 322 | + | |
|---|
| 323 | + | Req. No. 1217 Page 5 1 |
|---|
| 324 | + | 2 |
|---|
| 325 | + | 3 |
|---|
| 326 | + | 4 |
|---|
| 327 | + | 5 |
|---|
| 328 | + | 6 |
|---|
| 329 | + | 7 |
|---|
| 330 | + | 8 |
|---|
| 331 | + | 9 |
|---|
| 332 | + | 10 |
|---|
| 333 | + | 11 |
|---|
| 334 | + | 12 |
|---|
| 335 | + | 13 |
|---|
| 336 | + | 14 |
|---|
| 337 | + | 15 |
|---|
| 338 | + | 16 |
|---|
| 339 | + | 17 |
|---|
| 340 | + | 18 |
|---|
| 341 | + | 19 |
|---|
| 342 | + | 20 |
|---|
| 343 | + | 21 |
|---|
| 344 | + | 22 |
|---|
| 345 | + | 23 |
|---|
| 346 | + | 24 |
|---|
| 347 | + | 1 |
|---|
| 348 | + | 2 |
|---|
| 349 | + | 3 |
|---|
| 350 | + | 4 |
|---|
| 351 | + | 5 |
|---|
| 352 | + | 6 |
|---|
| 353 | + | 7 |
|---|
| 354 | + | 8 |
|---|
| 355 | + | 9 |
|---|
| 356 | + | 10 |
|---|
| 357 | + | 11 |
|---|
| 358 | + | 12 |
|---|
| 359 | + | 13 |
|---|
| 360 | + | 14 |
|---|
| 361 | + | 15 |
|---|
| 362 | + | 16 |
|---|
| 363 | + | 17 |
|---|
| 364 | + | 18 |
|---|
| 365 | + | 19 |
|---|
| 366 | + | 20 |
|---|
| 367 | + | 21 |
|---|
| 368 | + | 22 |
|---|
| 369 | + | 23 |
|---|
| 370 | + | 24 |
|---|
| 371 | + | |
|---|
| 372 | + | 5. Total rebates, discounts, and price concessions received or |
|---|
| 373 | + | negotiated directly with the manufacturer in the immediately |
|---|
| 374 | + | preceding calendar year, for business in this state, in total and |
|---|
| 375 | + | for each payer type as deemed necessary by the Department; |
|---|
| 376 | + | 6. Projected total rebates, discounts, and price concessions |
|---|
| 377 | + | that the PBM expects to receive or to negotiate direc tly with the |
|---|
| 378 | + | manufacturer in the current cal endar year, for business in this |
|---|
| 379 | + | state, in total and for each payer type as deemed necessary by the |
|---|
| 380 | + | Department; |
|---|
| 381 | + | 7. Total discounts, dispensing fees, and other fees paid o r |
|---|
| 382 | + | allowed to pharmacies, prescription dru g networks, or pharmacy |
|---|
| 383 | + | services administrat ive organizations in the immediately preceding |
|---|
| 384 | + | calendar year, for b usiness in this state, in total and for each |
|---|
| 385 | + | payer type as deemed necessary by the Department; |
|---|
| 386 | + | 8. Projected total discounts, dispensing fees, an d other fees |
|---|
| 387 | + | that the PBM expects to pay or allow to pharmacies, prescription |
|---|
| 388 | + | drug networks, or pharmacy servic es administrative organizations in |
|---|
| 389 | + | the current calendar year, for business in this state, in total and |
|---|
| 390 | + | for each payer type as deemed necessary by the Department; |
|---|
| 391 | + | 9. Total net income receiv ed in the immediately preceding |
|---|
| 392 | + | calendar year for business in this state, in total and for each |
|---|
| 393 | + | payer type as deemed necessary by the Department; |
|---|
| 394 | + | |
|---|
| 395 | + | |
|---|
| 396 | + | Req. No. 1217 Page 6 1 |
|---|
| 397 | + | 2 |
|---|
| 398 | + | 3 |
|---|
| 399 | + | 4 |
|---|
| 400 | + | 5 |
|---|
| 401 | + | 6 |
|---|
| 402 | + | 7 |
|---|
| 403 | + | 8 |
|---|
| 404 | + | 9 |
|---|
| 405 | + | 10 |
|---|
| 406 | + | 11 |
|---|
| 407 | + | 12 |
|---|
| 408 | + | 13 |
|---|
| 409 | + | 14 |
|---|
| 410 | + | 15 |
|---|
| 411 | + | 16 |
|---|
| 412 | + | 17 |
|---|
| 413 | + | 18 |
|---|
| 414 | + | 19 |
|---|
| 415 | + | 20 |
|---|
| 416 | + | 21 |
|---|
| 417 | + | 22 |
|---|
| 418 | + | 23 |
|---|
| 419 | + | 24 |
|---|
| 420 | + | 1 |
|---|
| 421 | + | 2 |
|---|
| 422 | + | 3 |
|---|
| 423 | + | 4 |
|---|
| 424 | + | 5 |
|---|
| 425 | + | 6 |
|---|
| 426 | + | 7 |
|---|
| 427 | + | 8 |
|---|
| 428 | + | 9 |
|---|
| 429 | + | 10 |
|---|
| 430 | + | 11 |
|---|
| 431 | + | 12 |
|---|
| 432 | + | 13 |
|---|
| 433 | + | 14 |
|---|
| 434 | + | 15 |
|---|
| 435 | + | 16 |
|---|
| 436 | + | 17 |
|---|
| 437 | + | 18 |
|---|
| 438 | + | 19 |
|---|
| 439 | + | 20 |
|---|
| 440 | + | 21 |
|---|
| 441 | + | 22 |
|---|
| 442 | + | 23 |
|---|
| 443 | + | 24 |
|---|
| 444 | + | |
|---|
| 445 | + | 10. Projected net incom e that the PBM expects to receive in the |
|---|
| 446 | + | current calendar year for business in this s tate, in total and for |
|---|
| 447 | + | each payer type as deemed necessary by the D epartment; and |
|---|
| 448 | + | 11. Any other information as prescribed by the Department. |
|---|
| 449 | + | SECTION 3. NEW LAW A new sec tion of law to be codified |
|---|
| 450 | + | in the Oklahoma Statutes as Secti on 6973 of Title 36, unless there |
|---|
| 451 | + | is created a duplication in numb ering, reads as follows: |
|---|
| 452 | + | A. 1. A manufacturer shall notify the Insurance Department if |
|---|
| 453 | + | it is increasing the wholesale acquisition cost of a brand-name drug |
|---|
| 454 | + | by more than twenty percent (20%) per wholesale acqu isition cost |
|---|
| 455 | + | unit (WAC unit) during any twelve -month period, or if it is |
|---|
| 456 | + | increasing the wholesale acquisition cost of a generic drug priced |
|---|
| 457 | + | at Ten Dollars ($10.00) or more per WAC unit by more than twenty |
|---|
| 458 | + | percent (20%) during any twelve month period. The notice shall be |
|---|
| 459 | + | provided, in writing, at least sixty (60) days prior to the planned |
|---|
| 460 | + | effective date of the increase. |
|---|
| 461 | + | 2. A manufacturer that is required to notify the Department |
|---|
| 462 | + | under this subsection shall report to the Department , at least |
|---|
| 463 | + | thirty (30) days before the planned effective date of the increase, |
|---|
| 464 | + | the following: |
|---|
| 465 | + | a. drug identification details, including the drug group, |
|---|
| 466 | + | b. four (4) year sales history in WAC units for sales in |
|---|
| 467 | + | this state and in the United States, |
|---|
| 468 | + | c. the wholesale acquisition cost of the drug, |
|---|
| 469 | + | |
|---|
| 470 | + | |
|---|
| 471 | + | Req. No. 1217 Page 7 1 |
|---|
| 472 | + | 2 |
|---|
| 473 | + | 3 |
|---|
| 474 | + | 4 |
|---|
| 475 | + | 5 |
|---|
| 476 | + | 6 |
|---|
| 477 | + | 7 |
|---|
| 478 | + | 8 |
|---|
| 479 | + | 9 |
|---|
| 480 | + | 10 |
|---|
| 481 | + | 11 |
|---|
| 482 | + | 12 |
|---|
| 483 | + | 13 |
|---|
| 484 | + | 14 |
|---|
| 485 | + | 15 |
|---|
| 486 | + | 16 |
|---|
| 487 | + | 17 |
|---|
| 488 | + | 18 |
|---|
| 489 | + | 19 |
|---|
| 490 | + | 20 |
|---|
| 491 | + | 21 |
|---|
| 492 | + | 22 |
|---|
| 493 | + | 23 |
|---|
| 494 | + | 24 |
|---|
| 495 | + | 1 |
|---|
| 496 | + | 2 |
|---|
| 497 | + | 3 |
|---|
| 498 | + | 4 |
|---|
| 499 | + | 5 |
|---|
| 500 | + | 6 |
|---|
| 501 | + | 7 |
|---|
| 502 | + | 8 |
|---|
| 503 | + | 9 |
|---|
| 504 | + | 10 |
|---|
| 505 | + | 11 |
|---|
| 506 | + | 12 |
|---|
| 507 | + | 13 |
|---|
| 508 | + | 14 |
|---|
| 509 | + | 15 |
|---|
| 510 | + | 16 |
|---|
| 511 | + | 17 |
|---|
| 512 | + | 18 |
|---|
| 513 | + | 19 |
|---|
| 514 | + | 20 |
|---|
| 515 | + | 21 |
|---|
| 516 | + | 22 |
|---|
| 517 | + | 23 |
|---|
| 518 | + | 24 |
|---|
| 519 | + | |
|---|
| 520 | + | d. four (4) year revenue history from sales in this state |
|---|
| 521 | + | and in the United States, and |
|---|
| 522 | + | e. cost associated with sales in the United States by |
|---|
| 523 | + | drug and drug group. |
|---|
| 524 | + | B. 1. A manufacturer shall notify the Department if it intends |
|---|
| 525 | + | to introduce a new drug in the United States that has a wholesa le |
|---|
| 526 | + | acquisition cost of more than Six Hundred Seventy Dollars ($670.00) |
|---|
| 527 | + | per WAC unit. The notice shall be p rovided, in writing, at least |
|---|
| 528 | + | sixty (60) days prior to market introduction. |
|---|
| 529 | + | 2. A manufacturer that is required to notify the Department |
|---|
| 530 | + | under this subsection shall report to the Department , at least |
|---|
| 531 | + | thirty (30) days before the planned effective date of the increase, |
|---|
| 532 | + | the following: |
|---|
| 533 | + | a. drug identification details, including the drug group, |
|---|
| 534 | + | b. patient volume, revenue, and price, and |
|---|
| 535 | + | c. wholesale acquisition cost at introduction. |
|---|
| 536 | + | SECTION 4. NEW LAW A new section of law to be codified |
|---|
| 537 | + | in the Oklahoma Statutes as Section 6974 of Title 36, unless there |
|---|
| 538 | + | is created a duplication in numb ering, reads as follows: |
|---|
| 539 | + | Any wholesale drug distributor operating in this sta te shall |
|---|
| 540 | + | report annually to the Insurance Department, within sixty (60) days |
|---|
| 541 | + | after receiving notice from the Department indicating the specific |
|---|
| 542 | + | drugs for which reporting is re quired, the following information: |
|---|
| 543 | + | |
|---|
| 544 | + | |
|---|
| 545 | + | Req. No. 1217 Page 8 1 |
|---|
| 546 | + | 2 |
|---|
| 547 | + | 3 |
|---|
| 548 | + | 4 |
|---|
| 549 | + | 5 |
|---|
| 550 | + | 6 |
|---|
| 551 | + | 7 |
|---|
| 552 | + | 8 |
|---|
| 553 | + | 9 |
|---|
| 554 | + | 10 |
|---|
| 555 | + | 11 |
|---|
| 556 | + | 12 |
|---|
| 557 | + | 13 |
|---|
| 558 | + | 14 |
|---|
| 559 | + | 15 |
|---|
| 560 | + | 16 |
|---|
| 561 | + | 17 |
|---|
| 562 | + | 18 |
|---|
| 563 | + | 19 |
|---|
| 564 | + | 20 |
|---|
| 565 | + | 21 |
|---|
| 566 | + | 22 |
|---|
| 567 | + | 23 |
|---|
| 568 | + | 24 |
|---|
| 569 | + | 1 |
|---|
| 570 | + | 2 |
|---|
| 571 | + | 3 |
|---|
| 572 | + | 4 |
|---|
| 573 | + | 5 |
|---|
| 574 | + | 6 |
|---|
| 575 | + | 7 |
|---|
| 576 | + | 8 |
|---|
| 577 | + | 9 |
|---|
| 578 | + | 10 |
|---|
| 579 | + | 11 |
|---|
| 580 | + | 12 |
|---|
| 581 | + | 13 |
|---|
| 582 | + | 14 |
|---|
| 583 | + | 15 |
|---|
| 584 | + | 16 |
|---|
| 585 | + | 17 |
|---|
| 586 | + | 18 |
|---|
| 587 | + | 19 |
|---|
| 588 | + | 20 |
|---|
| 589 | + | 21 |
|---|
| 590 | + | 22 |
|---|
| 591 | + | 23 |
|---|
| 592 | + | 24 |
|---|
| 593 | + | |
|---|
| 594 | + | 1. The minimum and maximum who lesale acquisition cost f or each |
|---|
| 595 | + | indicated drug and drug group for which the distributor has |
|---|
| 596 | + | negotiated directly with the manufacturer in the immediately |
|---|
| 597 | + | preceding calendar year, related to prescriptio ns under an insurance |
|---|
| 598 | + | policy issued in this state; |
|---|
| 599 | + | 2. The minimum and maximum wholesale acquisition c ost for each |
|---|
| 600 | + | indicated drug and drug group for which the distributor has |
|---|
| 601 | + | negotiated directly with the manufacturer in the current calendar |
|---|
| 602 | + | year, related to prescriptions under an insurance policy issued in |
|---|
| 603 | + | this state; |
|---|
| 604 | + | 3. The number of WAC units for which the distributor negotiated |
|---|
| 605 | + | directly with the manufacturer in the immedi ately preceding calendar |
|---|
| 606 | + | year, for business in this state , in total and for each pa yer type |
|---|
| 607 | + | as deemed necessary by the Department; |
|---|
| 608 | + | 4. The projected number of WAC units for which the distributor |
|---|
| 609 | + | expects to negotiate directly with the manufacturer in the current |
|---|
| 610 | + | calendar year, for business in this state, in total and for each |
|---|
| 611 | + | payer type as deemed necessary b y the Department; |
|---|
| 612 | + | 5. Total rebates, discounts, and price c oncessions received o r |
|---|
| 613 | + | negotiated directly with the manufacturer in the immediately |
|---|
| 614 | + | preceding calendar year, for business in this state, in total and |
|---|
| 615 | + | for each payer type as de emed necessary by the Department; |
|---|
| 616 | + | 6. Projected total rebates, discounts, and pri ce concessions |
|---|
| 617 | + | that the distributor expects to receive or to negotiate directly |
|---|
| 618 | + | |
|---|
| 619 | + | |
|---|
| 620 | + | Req. No. 1217 Page 9 1 |
|---|
| 621 | + | 2 |
|---|
| 622 | + | 3 |
|---|
| 623 | + | 4 |
|---|
| 624 | + | 5 |
|---|
| 625 | + | 6 |
|---|
| 626 | + | 7 |
|---|
| 627 | + | 8 |
|---|
| 628 | + | 9 |
|---|
| 629 | + | 10 |
|---|
| 630 | + | 11 |
|---|
| 631 | + | 12 |
|---|
| 632 | + | 13 |
|---|
| 633 | + | 14 |
|---|
| 634 | + | 15 |
|---|
| 635 | + | 16 |
|---|
| 636 | + | 17 |
|---|
| 637 | + | 18 |
|---|
| 638 | + | 19 |
|---|
| 639 | + | 20 |
|---|
| 640 | + | 21 |
|---|
| 641 | + | 22 |
|---|
| 642 | + | 23 |
|---|
| 643 | + | 24 |
|---|
| 644 | + | 1 |
|---|
| 645 | + | 2 |
|---|
| 646 | + | 3 |
|---|
| 647 | + | 4 |
|---|
| 648 | + | 5 |
|---|
| 649 | + | 6 |
|---|
| 650 | + | 7 |
|---|
| 651 | + | 8 |
|---|
| 652 | + | 9 |
|---|
| 653 | + | 10 |
|---|
| 654 | + | 11 |
|---|
| 655 | + | 12 |
|---|
| 656 | + | 13 |
|---|
| 657 | + | 14 |
|---|
| 658 | + | 15 |
|---|
| 659 | + | 16 |
|---|
| 660 | + | 17 |
|---|
| 661 | + | 18 |
|---|
| 662 | + | 19 |
|---|
| 663 | + | 20 |
|---|
| 664 | + | 21 |
|---|
| 665 | + | 22 |
|---|
| 666 | + | 23 |
|---|
| 667 | + | 24 |
|---|
| 668 | + | |
|---|
| 669 | + | with the manufacturer in the current calendar year, for business in |
|---|
| 670 | + | this state, in total and for each payer type as deemed necessary by |
|---|
| 671 | + | the Department; |
|---|
| 672 | + | 7. Total discounts, dispensing fees, and other fees paid or |
|---|
| 673 | + | allowed to pharmacies, prescription drug net works, or pharmacy |
|---|
| 674 | + | services administrati ve organizations in the immediately preceding |
|---|
| 675 | + | calendar year, for business in this state, in total and for each |
|---|
| 676 | + | payer type as deemed nec essary by the Department; |
|---|
| 677 | + | 8. Projected total di scounts, dispensing fees, and other fees |
|---|
| 678 | + | that the PBM expects to pay or allow to pharmacies, prescription |
|---|
| 679 | + | drug networks, or pharmacy services administrative organizations in |
|---|
| 680 | + | the current calendar year, for bus iness in this state, i n total and |
|---|
| 681 | + | for each payer type as deemed necessary by the Department; |
|---|
| 682 | + | 9. Total net income received in the immediately preceding |
|---|
| 683 | + | calendar year for busines s in this state, in total and for e ach |
|---|
| 684 | + | payer type as deemed necessary by the De partment; |
|---|
| 685 | + | 10. Projected net income that the distributor expects to |
|---|
| 686 | + | receive in the current c alendar year for business in this state, in |
|---|
| 687 | + | total and for each payer type as deemed necessary by the Department; |
|---|
| 688 | + | and |
|---|
| 689 | + | 11. Any other information as prescribed by th e Department. |
|---|
| 690 | + | SECTION 5. NEW LAW A new section of law to be codified |
|---|
| 691 | + | in the Oklahoma Statutes as S ection 6975 of Title 36, unless there |
|---|
| 692 | + | is created a duplication in numbering, reads as follows: |
|---|
| 693 | + | |
|---|
| 694 | + | |
|---|
| 695 | + | Req. No. 1217 Page 10 1 |
|---|
| 696 | + | 2 |
|---|
| 697 | + | 3 |
|---|
| 698 | + | 4 |
|---|
| 699 | + | 5 |
|---|
| 700 | + | 6 |
|---|
| 701 | + | 7 |
|---|
| 702 | + | 8 |
|---|
| 703 | + | 9 |
|---|
| 704 | + | 10 |
|---|
| 705 | + | 11 |
|---|
| 706 | + | 12 |
|---|
| 707 | + | 13 |
|---|
| 708 | + | 14 |
|---|
| 709 | + | 15 |
|---|
| 710 | + | 16 |
|---|
| 711 | + | 17 |
|---|
| 712 | + | 18 |
|---|
| 713 | + | 19 |
|---|
| 714 | + | 20 |
|---|
| 715 | + | 21 |
|---|
| 716 | + | 22 |
|---|
| 717 | + | 23 |
|---|
| 718 | + | 24 |
|---|
| 719 | + | 1 |
|---|
| 720 | + | 2 |
|---|
| 721 | + | 3 |
|---|
| 722 | + | 4 |
|---|
| 723 | + | 5 |
|---|
| 724 | + | 6 |
|---|
| 725 | + | 7 |
|---|
| 726 | + | 8 |
|---|
| 727 | + | 9 |
|---|
| 728 | + | 10 |
|---|
| 729 | + | 11 |
|---|
| 730 | + | 12 |
|---|
| 731 | + | 13 |
|---|
| 732 | + | 14 |
|---|
| 733 | + | 15 |
|---|
| 734 | + | 16 |
|---|
| 735 | + | 17 |
|---|
| 736 | + | 18 |
|---|
| 737 | + | 19 |
|---|
| 738 | + | 20 |
|---|
| 739 | + | 21 |
|---|
| 740 | + | 22 |
|---|
| 741 | + | 23 |
|---|
| 742 | + | 24 |
|---|
| 743 | + | |
|---|
| 744 | + | A. Each insurer designat ed by the Insurance Department as a |
|---|
| 745 | + | reporting entity shall report annually to the Department, to the |
|---|
| 746 | + | extent allowed by law, spending on prescription drugs before |
|---|
| 747 | + | enrollee cost sharing, in tota l and per prescription drug user, and |
|---|
| 748 | + | spending on the top twenty-five (25) prescription drugs prescribed |
|---|
| 749 | + | in this state, in total and individually, as determined by the |
|---|
| 750 | + | Insurance Department. The repor t shall include: |
|---|
| 751 | + | 1. The greatest total spending before enrollee cost sharing in |
|---|
| 752 | + | the immediately preceding calendar year; |
|---|
| 753 | + | 2. The greatest total spending per user of any drug before |
|---|
| 754 | + | enrollee cost sharing in the immediately preceding calendar year; |
|---|
| 755 | + | 3. The highest year-over-year increase in total spending before |
|---|
| 756 | + | enrollee cost sharing; and |
|---|
| 757 | + | 4. The highest year-over-year increase in total spend ing per |
|---|
| 758 | + | user of any drug before enrollee cost sharing. |
|---|
| 759 | + | B. For each drug and drug group, the insurer shall report to |
|---|
| 760 | + | the Department, within sixty (60) days of the close of ea ch calendar |
|---|
| 761 | + | year, the following information: |
|---|
| 762 | + | 1. For drugs that accounted for the highest total spending |
|---|
| 763 | + | before enrollee cost sharing in the last calendar year: |
|---|
| 764 | + | a. total spending before enrollee cost sharing in the |
|---|
| 765 | + | immediately preceding calendar year, |
|---|
| 766 | + | b. projected total spending before enrollee cost sharing |
|---|
| 767 | + | in the current calendar year, |
|---|
| 768 | + | |
|---|
| 769 | + | |
|---|
| 770 | + | Req. No. 1217 Page 11 1 |
|---|
| 771 | + | 2 |
|---|
| 772 | + | 3 |
|---|
| 773 | + | 4 |
|---|
| 774 | + | 5 |
|---|
| 775 | + | 6 |
|---|
| 776 | + | 7 |
|---|
| 777 | + | 8 |
|---|
| 778 | + | 9 |
|---|
| 779 | + | 10 |
|---|
| 780 | + | 11 |
|---|
| 781 | + | 12 |
|---|
| 782 | + | 13 |
|---|
| 783 | + | 14 |
|---|
| 784 | + | 15 |
|---|
| 785 | + | 16 |
|---|
| 786 | + | 17 |
|---|
| 787 | + | 18 |
|---|
| 788 | + | 19 |
|---|
| 789 | + | 20 |
|---|
| 790 | + | 21 |
|---|
| 791 | + | 22 |
|---|
| 792 | + | 23 |
|---|
| 793 | + | 24 |
|---|
| 794 | + | 1 |
|---|
| 795 | + | 2 |
|---|
| 796 | + | 3 |
|---|
| 797 | + | 4 |
|---|
| 798 | + | 5 |
|---|
| 799 | + | 6 |
|---|
| 800 | + | 7 |
|---|
| 801 | + | 8 |
|---|
| 802 | + | 9 |
|---|
| 803 | + | 10 |
|---|
| 804 | + | 11 |
|---|
| 805 | + | 12 |
|---|
| 806 | + | 13 |
|---|
| 807 | + | 14 |
|---|
| 808 | + | 15 |
|---|
| 809 | + | 16 |
|---|
| 810 | + | 17 |
|---|
| 811 | + | 18 |
|---|
| 812 | + | 19 |
|---|
| 813 | + | 20 |
|---|
| 814 | + | 21 |
|---|
| 815 | + | 22 |
|---|
| 816 | + | 23 |
|---|
| 817 | + | 24 |
|---|
| 818 | + | |
|---|
| 819 | + | c margins and fees paid directly to pharmacy benefit |
|---|
| 820 | + | managers (PBMs) or pharmacy services administrative |
|---|
| 821 | + | organizations in the immediately preceding calendar |
|---|
| 822 | + | year, and |
|---|
| 823 | + | d. other allowed retail discounts, pr ice concessions, and |
|---|
| 824 | + | fees paid in the immediately preceding calendar year; |
|---|
| 825 | + | 2. For drugs that accounted for the highest year-over-year |
|---|
| 826 | + | change in total spending before enrollee cost sharing: |
|---|
| 827 | + | a. year-over-year change in total spending before |
|---|
| 828 | + | enrollee cost sharing, |
|---|
| 829 | + | b. total spending before enrollee cost sharing in the |
|---|
| 830 | + | immediately preceding calendar year, |
|---|
| 831 | + | c. projected total spending before enrollee cost sh aring |
|---|
| 832 | + | in the current calendar year, |
|---|
| 833 | + | d. margins and fees paid di rectly to PBMs or pharmacy |
|---|
| 834 | + | services administrative organizations in the |
|---|
| 835 | + | immediately preceding calendar year, and |
|---|
| 836 | + | e. other allowed retail discounts, price con cessions, and |
|---|
| 837 | + | fees paid in the immediately preceding calendar year; |
|---|
| 838 | + | 3. For drugs that accounted fo r the highest total spending per |
|---|
| 839 | + | user before enrollee cost sharing in the imm ediately preceding |
|---|
| 840 | + | calendar year: |
|---|
| 841 | + | a. total spending per user before enrollee cost sharing |
|---|
| 842 | + | in the immediately preceding calendar year, |
|---|
| 843 | + | |
|---|
| 844 | + | |
|---|
| 845 | + | Req. No. 1217 Page 12 1 |
|---|
| 846 | + | 2 |
|---|
| 847 | + | 3 |
|---|
| 848 | + | 4 |
|---|
| 849 | + | 5 |
|---|
| 850 | + | 6 |
|---|
| 851 | + | 7 |
|---|
| 852 | + | 8 |
|---|
| 853 | + | 9 |
|---|
| 854 | + | 10 |
|---|
| 855 | + | 11 |
|---|
| 856 | + | 12 |
|---|
| 857 | + | 13 |
|---|
| 858 | + | 14 |
|---|
| 859 | + | 15 |
|---|
| 860 | + | 16 |
|---|
| 861 | + | 17 |
|---|
| 862 | + | 18 |
|---|
| 863 | + | 19 |
|---|
| 864 | + | 20 |
|---|
| 865 | + | 21 |
|---|
| 866 | + | 22 |
|---|
| 867 | + | 23 |
|---|
| 868 | + | 24 |
|---|
| 869 | + | 1 |
|---|
| 870 | + | 2 |
|---|
| 871 | + | 3 |
|---|
| 872 | + | 4 |
|---|
| 873 | + | 5 |
|---|
| 874 | + | 6 |
|---|
| 875 | + | 7 |
|---|
| 876 | + | 8 |
|---|
| 877 | + | 9 |
|---|
| 878 | + | 10 |
|---|
| 879 | + | 11 |
|---|
| 880 | + | 12 |
|---|
| 881 | + | 13 |
|---|
| 882 | + | 14 |
|---|
| 883 | + | 15 |
|---|
| 884 | + | 16 |
|---|
| 885 | + | 17 |
|---|
| 886 | + | 18 |
|---|
| 887 | + | 19 |
|---|
| 888 | + | 20 |
|---|
| 889 | + | 21 |
|---|
| 890 | + | 22 |
|---|
| 891 | + | 23 |
|---|
| 892 | + | 24 |
|---|
| 893 | + | |
|---|
| 894 | + | b. total spending before enrollee cost sharin g in the |
|---|
| 895 | + | immediately preceding calendar year, |
|---|
| 896 | + | c. number of users in the immediately preceding calendar |
|---|
| 897 | + | year, |
|---|
| 898 | + | d. projected total spending per user before enrollee cost |
|---|
| 899 | + | sharing in the current calendar year , |
|---|
| 900 | + | e. margins and fees paid directly to PBMs or pharma cy |
|---|
| 901 | + | services administrative organizations in the |
|---|
| 902 | + | immediately preceding calendar year, and |
|---|
| 903 | + | f. other allowed retail discounts, price con cessions, and |
|---|
| 904 | + | fees paid in the immediately preceding calendar year; |
|---|
| 905 | + | and |
|---|
| 906 | + | 4. For drugs that accounted for the highest year -over-year |
|---|
| 907 | + | change in total spending per user before enrollee cost sharing in |
|---|
| 908 | + | the immediately preceding calen dar year: |
|---|
| 909 | + | a. year-over-year change in total sp ending per user |
|---|
| 910 | + | before enrollee cost sharing, |
|---|
| 911 | + | b. total spending per user before enrollee cost sharing |
|---|
| 912 | + | in the immediately preceding calendar year , |
|---|
| 913 | + | c. number of users in the immediately preceding calendar |
|---|
| 914 | + | year, |
|---|
| 915 | + | d. projected total spending per user before enrollee cost |
|---|
| 916 | + | sharing in the current c alendar year, |
|---|
| 917 | + | |
|---|
| 918 | + | |
|---|
| 919 | + | Req. No. 1217 Page 13 1 |
|---|
| 920 | + | 2 |
|---|
| 921 | + | 3 |
|---|
| 922 | + | 4 |
|---|
| 923 | + | 5 |
|---|
| 924 | + | 6 |
|---|
| 925 | + | 7 |
|---|
| 926 | + | 8 |
|---|
| 927 | + | 9 |
|---|
| 928 | + | 10 |
|---|
| 929 | + | 11 |
|---|
| 930 | + | 12 |
|---|
| 931 | + | 13 |
|---|
| 932 | + | 14 |
|---|
| 933 | + | 15 |
|---|
| 934 | + | 16 |
|---|
| 935 | + | 17 |
|---|
| 936 | + | 18 |
|---|
| 937 | + | 19 |
|---|
| 938 | + | 20 |
|---|
| 939 | + | 21 |
|---|
| 940 | + | 22 |
|---|
| 941 | + | 23 |
|---|
| 942 | + | 24 |
|---|
| 943 | + | 1 |
|---|
| 944 | + | 2 |
|---|
| 945 | + | 3 |
|---|
| 946 | + | 4 |
|---|
| 947 | + | 5 |
|---|
| 948 | + | 6 |
|---|
| 949 | + | 7 |
|---|
| 950 | + | 8 |
|---|
| 951 | + | 9 |
|---|
| 952 | + | 10 |
|---|
| 953 | + | 11 |
|---|
| 954 | + | 12 |
|---|
| 955 | + | 13 |
|---|
| 956 | + | 14 |
|---|
| 957 | + | 15 |
|---|
| 958 | + | 16 |
|---|
| 959 | + | 17 |
|---|
| 960 | + | 18 |
|---|
| 961 | + | 19 |
|---|
| 962 | + | 20 |
|---|
| 963 | + | 21 |
|---|
| 964 | + | 22 |
|---|
| 965 | + | 23 |
|---|
| 966 | + | 24 |
|---|
| 967 | + | |
|---|
| 968 | + | e. margins and fees paid directly to PBM s or pharmacy |
|---|
| 969 | + | services administrative organizations in the |
|---|
| 970 | + | immediately preceding calend ar year, and |
|---|
| 971 | + | f. other allowed retail discounts, pr ice concessions, and |
|---|
| 972 | + | fees in the last calendar year. |
|---|
| 973 | + | C. Disclosure of all information repo rted under this section is |
|---|
| 974 | + | subject to the protections described in Section 6 of this act. |
|---|
| 975 | + | SECTION 6. NEW LAW A new s ection of law to be codified |
|---|
| 976 | + | in the Oklahoma Statutes as Section 6976 of Title 36, unless there |
|---|
| 977 | + | is created a duplication in numbering, reads as foll ows: |
|---|
| 978 | + | A. Beginning on January 1, 2024, each reporti ng entity shall |
|---|
| 979 | + | register with the Insurance De partment no later th an January 31 of |
|---|
| 980 | + | each calendar year, in a form and manner specifi ed by the |
|---|
| 981 | + | Department. |
|---|
| 982 | + | B. 1. Each reporting entity shall pay an annual a ssessment, in |
|---|
| 983 | + | an amount to be determined by the Department but not to be less than |
|---|
| 984 | + | One Hundred Dollars ($100.00) for each individual entity required to |
|---|
| 985 | + | pay an assessment under this act, to support the operational costs |
|---|
| 986 | + | of the Department in implementing the provisions of this act. The |
|---|
| 987 | + | costs shall include staff salaries, administrative expe nses, data |
|---|
| 988 | + | system expenses, and consulting fees of the De partment. The total |
|---|
| 989 | + | annual assessments shall be based on the total annual allocation |
|---|
| 990 | + | authorized by the Legislature for the operational costs of the |
|---|
| 991 | + | Department under this act, as indicated in t he fiscal year budget of |
|---|
| 992 | + | |
|---|
| 993 | + | |
|---|
| 994 | + | Req. No. 1217 Page 14 1 |
|---|
| 995 | + | 2 |
|---|
| 996 | + | 3 |
|---|
| 997 | + | 4 |
|---|
| 998 | + | 5 |
|---|
| 999 | + | 6 |
|---|
| 1000 | + | 7 |
|---|
| 1001 | + | 8 |
|---|
| 1002 | + | 9 |
|---|
| 1003 | + | 10 |
|---|
| 1004 | + | 11 |
|---|
| 1005 | + | 12 |
|---|
| 1006 | + | 13 |
|---|
| 1007 | + | 14 |
|---|
| 1008 | + | 15 |
|---|
| 1009 | + | 16 |
|---|
| 1010 | + | 17 |
|---|
| 1011 | + | 18 |
|---|
| 1012 | + | 19 |
|---|
| 1013 | + | 20 |
|---|
| 1014 | + | 21 |
|---|
| 1015 | + | 22 |
|---|
| 1016 | + | 23 |
|---|
| 1017 | + | 24 |
|---|
| 1018 | + | 1 |
|---|
| 1019 | + | 2 |
|---|
| 1020 | + | 3 |
|---|
| 1021 | + | 4 |
|---|
| 1022 | + | 5 |
|---|
| 1023 | + | 6 |
|---|
| 1024 | + | 7 |
|---|
| 1025 | + | 8 |
|---|
| 1026 | + | 9 |
|---|
| 1027 | + | 10 |
|---|
| 1028 | + | 11 |
|---|
| 1029 | + | 12 |
|---|
| 1030 | + | 13 |
|---|
| 1031 | + | 14 |
|---|
| 1032 | + | 15 |
|---|
| 1033 | + | 16 |
|---|
| 1034 | + | 17 |
|---|
| 1035 | + | 18 |
|---|
| 1036 | + | 19 |
|---|
| 1037 | + | 20 |
|---|
| 1038 | + | 21 |
|---|
| 1039 | + | 22 |
|---|
| 1040 | + | 23 |
|---|
| 1041 | + | 24 |
|---|
| 1042 | + | |
|---|
| 1043 | + | the Department. The amount to be assessed shall be reduced by the |
|---|
| 1044 | + | difference between the total annual authorized allocation for the |
|---|
| 1045 | + | next fiscal year and the beginning fund balance in the Department’s |
|---|
| 1046 | + | account for the prior fiscal year. Any assessment reduction s hall |
|---|
| 1047 | + | be applied proportiona tely to the categorical groups assesse d. |
|---|
| 1048 | + | 2. The assessments shall be p laced in State Insurance |
|---|
| 1049 | + | Commissioner Revolving Fund pursuant to Section 307.3 of Title 36 of |
|---|
| 1050 | + | the Oklahoma Statutes. |
|---|
| 1051 | + | C. The Department shall send request for payment of the |
|---|
| 1052 | + | assessment to all reporting entities under this act by certified |
|---|
| 1053 | + | mail beginning July 1, 2024, and annually thereafter. All |
|---|
| 1054 | + | assessments shall be due to the Department within thirty (30) days |
|---|
| 1055 | + | of receipt of the request for payment. Any reporting entity that |
|---|
| 1056 | + | fails to pay the assessment pursuant to th is act shall be subject to |
|---|
| 1057 | + | the penalties described under Section 7 of this act. |
|---|
| 1058 | + | SECTION 7. NEW LAW A new section of law to be codified |
|---|
| 1059 | + | in the Oklahoma Statutes as Section 6977 of Title 36, unless there |
|---|
| 1060 | + | is created a duplication in numb ering, reads as follows: |
|---|
| 1061 | + | A. The reporting entity sha ll certify required reporting under |
|---|
| 1062 | + | this act as accurate under penalty of perjury. |
|---|
| 1063 | + | B. Failure of a reporting entity to comply with the provisions |
|---|
| 1064 | + | of this act may result in a civil penalty, at the discr etion of the |
|---|
| 1065 | + | Insurance Commissioner. Civil penalties under this act shall not |
|---|
| 1066 | + | exceed Thirty Thousand Dollars ($30,000.00) per day that the |
|---|
| 1067 | + | |
|---|
| 1068 | + | |
|---|
| 1069 | + | Req. No. 1217 Page 15 1 |
|---|
| 1070 | + | 2 |
|---|
| 1071 | + | 3 |
|---|
| 1072 | + | 4 |
|---|
| 1073 | + | 5 |
|---|
| 1074 | + | 6 |
|---|
| 1075 | + | 7 |
|---|
| 1076 | + | 8 |
|---|
| 1077 | + | 9 |
|---|
| 1078 | + | 10 |
|---|
| 1079 | + | 11 |
|---|
| 1080 | + | 12 |
|---|
| 1081 | + | 13 |
|---|
| 1082 | + | 14 |
|---|
| 1083 | + | 15 |
|---|
| 1084 | + | 16 |
|---|
| 1085 | + | 17 |
|---|
| 1086 | + | 18 |
|---|
| 1087 | + | 19 |
|---|
| 1088 | + | 20 |
|---|
| 1089 | + | 21 |
|---|
| 1090 | + | 22 |
|---|
| 1091 | + | 23 |
|---|
| 1092 | + | 24 |
|---|
| 1093 | + | 1 |
|---|
| 1094 | + | 2 |
|---|
| 1095 | + | 3 |
|---|
| 1096 | + | 4 |
|---|
| 1097 | + | 5 |
|---|
| 1098 | + | 6 |
|---|
| 1099 | + | 7 |
|---|
| 1100 | + | 8 |
|---|
| 1101 | + | 9 |
|---|
| 1102 | + | 10 |
|---|
| 1103 | + | 11 |
|---|
| 1104 | + | 12 |
|---|
| 1105 | + | 13 |
|---|
| 1106 | + | 14 |
|---|
| 1107 | + | 15 |
|---|
| 1108 | + | 16 |
|---|
| 1109 | + | 17 |
|---|
| 1110 | + | 18 |
|---|
| 1111 | + | 19 |
|---|
| 1112 | + | 20 |
|---|
| 1113 | + | 21 |
|---|
| 1114 | + | 22 |
|---|
| 1115 | + | 23 |
|---|
| 1116 | + | 24 |
|---|
| 1117 | + | |
|---|
| 1118 | + | reporting entity is found to be in violation of the provisions of |
|---|
| 1119 | + | this act. |
|---|
| 1120 | + | C. The Insurance Department may audit the data submitted to the |
|---|
| 1121 | + | Department by a reporting ent ity pursuant to the provisions of th is |
|---|
| 1122 | + | act, in a form and manner to be specifi ed by the Department. The |
|---|
| 1123 | + | reporting entity shall pay all costs associated with the audit . |
|---|
| 1124 | + | D. The Department may require a reporting entity to subm it a |
|---|
| 1125 | + | corrective action plan, i n a form and manner to be specified by the |
|---|
| 1126 | + | Department, to correct deficiencies in reporting pursuant to the |
|---|
| 1127 | + | provisions of this act. |
|---|
| 1128 | + | E. The Department is au thorized to call one or more public |
|---|
| 1129 | + | hearings on the price of prescription drugs in this state and may |
|---|
| 1130 | + | subpoena any reporting entity pursuant to the provisions of this |
|---|
| 1131 | + | act. |
|---|
| 1132 | + | SECTION 8. NEW LAW A new section of law to be codified |
|---|
| 1133 | + | in the Oklahoma Statutes as Section 6978 of Title 36, unless there |
|---|
| 1134 | + | is created a duplication in numb ering, reads as follows: |
|---|
| 1135 | + | A. Not later than July 1, 2024, the Insurance Department shall |
|---|
| 1136 | + | develop and publish on its websi te a report on emerging trends in |
|---|
| 1137 | + | prescription drug prices in this state and conduct an annual public |
|---|
| 1138 | + | hearing based on the report findings. To make clear the main |
|---|
| 1139 | + | components of prescription drug pricing along the supply chain, the |
|---|
| 1140 | + | report shall include, bu t not be limited to, ana lyses of |
|---|
| 1141 | + | manufacturer prices and price increases as reported under th is act, |
|---|
| 1142 | + | |
|---|
| 1143 | + | |
|---|
| 1144 | + | Req. No. 1217 Page 16 1 |
|---|
| 1145 | + | 2 |
|---|
| 1146 | + | 3 |
|---|
| 1147 | + | 4 |
|---|
| 1148 | + | 5 |
|---|
| 1149 | + | 6 |
|---|
| 1150 | + | 7 |
|---|
| 1151 | + | 8 |
|---|
| 1152 | + | 9 |
|---|
| 1153 | + | 10 |
|---|
| 1154 | + | 11 |
|---|
| 1155 | + | 12 |
|---|
| 1156 | + | 13 |
|---|
| 1157 | + | 14 |
|---|
| 1158 | + | 15 |
|---|
| 1159 | + | 16 |
|---|
| 1160 | + | 17 |
|---|
| 1161 | + | 18 |
|---|
| 1162 | + | 19 |
|---|
| 1163 | + | 20 |
|---|
| 1164 | + | 21 |
|---|
| 1165 | + | 22 |
|---|
| 1166 | + | 23 |
|---|
| 1167 | + | 24 |
|---|
| 1168 | + | 1 |
|---|
| 1169 | + | 2 |
|---|
| 1170 | + | 3 |
|---|
| 1171 | + | 4 |
|---|
| 1172 | + | 5 |
|---|
| 1173 | + | 6 |
|---|
| 1174 | + | 7 |
|---|
| 1175 | + | 8 |
|---|
| 1176 | + | 9 |
|---|
| 1177 | + | 10 |
|---|
| 1178 | + | 11 |
|---|
| 1179 | + | 12 |
|---|
| 1180 | + | 13 |
|---|
| 1181 | + | 14 |
|---|
| 1182 | + | 15 |
|---|
| 1183 | + | 16 |
|---|
| 1184 | + | 17 |
|---|
| 1185 | + | 18 |
|---|
| 1186 | + | 19 |
|---|
| 1187 | + | 20 |
|---|
| 1188 | + | 21 |
|---|
| 1189 | + | 22 |
|---|
| 1190 | + | 23 |
|---|
| 1191 | + | 24 |
|---|
| 1192 | + | |
|---|
| 1193 | + | information reported under th is act by insurers, pharmacy benefits |
|---|
| 1194 | + | managers, and wholesale drug distributors, and the impacts on |
|---|
| 1195 | + | insurance premiums and consumer cost sharing. The data in the |
|---|
| 1196 | + | report shall not reveal information specific to any individual |
|---|
| 1197 | + | reporting entity. |
|---|
| 1198 | + | B. Except as provided in this section, the Department shall |
|---|
| 1199 | + | keep confidential all information submitted by an individual |
|---|
| 1200 | + | reporting entity and protect it from public disclosure. The |
|---|
| 1201 | + | Department may share such information with the Attorney General; |
|---|
| 1202 | + | provided, however that the Attorney General shall keep confidential |
|---|
| 1203 | + | any information shared by the Insurance Depa rtment. The information |
|---|
| 1204 | + | shall not be considered a record under the Oklahoma Open Records Act |
|---|
| 1205 | + | as defined pursuant to Section 24A.3 of Title 51 o f the Oklahoma |
|---|
| 1206 | + | Statutes. |
|---|
| 1207 | + | C. The Insurance Department shall promulgate rules to |
|---|
| 1208 | + | effectuate the provisions of this act. |
|---|
| 1209 | + | SECTION 9. AMENDATORY 51 O.S. 2021, Section 24A.3, as |
|---|
| 1210 | + | amended by Section 1, Chapter 402, O.S.L. 2022 (51 O.S. Supp. 2022, |
|---|
| 1211 | + | Section 24A.3), is amend ed to read as follows: |
|---|
| 1212 | + | Section 24A.3. As used in the Oklahoma Open Records Act: |
|---|
| 1213 | + | 1. “Record” means all documents including, but not limited to, |
|---|
| 1214 | + | any book, paper, photograph, microfilm, data files created by or |
|---|
| 1215 | + | used with computer software, computer tape, di sk, record, sound |
|---|
| 1216 | + | recording, film recording, video record or other material regardless |
|---|
| 1217 | + | |
|---|
| 1218 | + | |
|---|
| 1219 | + | Req. No. 1217 Page 17 1 |
|---|
| 1220 | + | 2 |
|---|
| 1221 | + | 3 |
|---|
| 1222 | + | 4 |
|---|
| 1223 | + | 5 |
|---|
| 1224 | + | 6 |
|---|
| 1225 | + | 7 |
|---|
| 1226 | + | 8 |
|---|
| 1227 | + | 9 |
|---|
| 1228 | + | 10 |
|---|
| 1229 | + | 11 |
|---|
| 1230 | + | 12 |
|---|
| 1231 | + | 13 |
|---|
| 1232 | + | 14 |
|---|
| 1233 | + | 15 |
|---|
| 1234 | + | 16 |
|---|
| 1235 | + | 17 |
|---|
| 1236 | + | 18 |
|---|
| 1237 | + | 19 |
|---|
| 1238 | + | 20 |
|---|
| 1239 | + | 21 |
|---|
| 1240 | + | 22 |
|---|
| 1241 | + | 23 |
|---|
| 1242 | + | 24 |
|---|
| 1243 | + | 1 |
|---|
| 1244 | + | 2 |
|---|
| 1245 | + | 3 |
|---|
| 1246 | + | 4 |
|---|
| 1247 | + | 5 |
|---|
| 1248 | + | 6 |
|---|
| 1249 | + | 7 |
|---|
| 1250 | + | 8 |
|---|
| 1251 | + | 9 |
|---|
| 1252 | + | 10 |
|---|
| 1253 | + | 11 |
|---|
| 1254 | + | 12 |
|---|
| 1255 | + | 13 |
|---|
| 1256 | + | 14 |
|---|
| 1257 | + | 15 |
|---|
| 1258 | + | 16 |
|---|
| 1259 | + | 17 |
|---|
| 1260 | + | 18 |
|---|
| 1261 | + | 19 |
|---|
| 1262 | + | 20 |
|---|
| 1263 | + | 21 |
|---|
| 1264 | + | 22 |
|---|
| 1265 | + | 23 |
|---|
| 1266 | + | 24 |
|---|
| 1267 | + | |
|---|
| 1268 | + | of physical form or charact eristic, created by, received by, under |
|---|
| 1269 | + | the authority of, or coming into the custody, control or possession |
|---|
| 1270 | + | of public officials, public bodies or their representatives in |
|---|
| 1271 | + | connection with the transaction of public bus iness, the expenditure |
|---|
| 1272 | + | of public funds or the administering of public property. “Record” |
|---|
| 1273 | + | Record does not mean: |
|---|
| 1274 | + | a. computer software, |
|---|
| 1275 | + | b. nongovernment personal effects, |
|---|
| 1276 | + | c. unless public disclosure is required by other laws or |
|---|
| 1277 | + | regulations, vehicle movement records of the Oklahoma |
|---|
| 1278 | + | Transportation Authorit y obtained in connection with |
|---|
| 1279 | + | the Authority’s electronic toll collection system, |
|---|
| 1280 | + | d. personal financial information, credit reports or |
|---|
| 1281 | + | other financial data obtained by or submitted to a |
|---|
| 1282 | + | public body for the purpose of evaluating credit |
|---|
| 1283 | + | worthiness, obtaining a license, permit or for the |
|---|
| 1284 | + | purpose of becoming qualified to contract with a |
|---|
| 1285 | + | public body, |
|---|
| 1286 | + | e. any digital audio/video recordings of the toll |
|---|
| 1287 | + | collection and safeguarding activities of the Oklahoma |
|---|
| 1288 | + | Transportation Authority, |
|---|
| 1289 | + | f. any personal information provid ed by a guest at any |
|---|
| 1290 | + | facility owned or operated by the Oklahoma Tourism and |
|---|
| 1291 | + | Recreation Department to obtain any service at t he |
|---|
| 1292 | + | |
|---|
| 1293 | + | |
|---|
| 1294 | + | Req. No. 1217 Page 18 1 |
|---|
| 1295 | + | 2 |
|---|
| 1296 | + | 3 |
|---|
| 1297 | + | 4 |
|---|
| 1298 | + | 5 |
|---|
| 1299 | + | 6 |
|---|
| 1300 | + | 7 |
|---|
| 1301 | + | 8 |
|---|
| 1302 | + | 9 |
|---|
| 1303 | + | 10 |
|---|
| 1304 | + | 11 |
|---|
| 1305 | + | 12 |
|---|
| 1306 | + | 13 |
|---|
| 1307 | + | 14 |
|---|
| 1308 | + | 15 |
|---|
| 1309 | + | 16 |
|---|
| 1310 | + | 17 |
|---|
| 1311 | + | 18 |
|---|
| 1312 | + | 19 |
|---|
| 1313 | + | 20 |
|---|
| 1314 | + | 21 |
|---|
| 1315 | + | 22 |
|---|
| 1316 | + | 23 |
|---|
| 1317 | + | 24 |
|---|
| 1318 | + | 1 |
|---|
| 1319 | + | 2 |
|---|
| 1320 | + | 3 |
|---|
| 1321 | + | 4 |
|---|
| 1322 | + | 5 |
|---|
| 1323 | + | 6 |
|---|
| 1324 | + | 7 |
|---|
| 1325 | + | 8 |
|---|
| 1326 | + | 9 |
|---|
| 1327 | + | 10 |
|---|
| 1328 | + | 11 |
|---|
| 1329 | + | 12 |
|---|
| 1330 | + | 13 |
|---|
| 1331 | + | 14 |
|---|
| 1332 | + | 15 |
|---|
| 1333 | + | 16 |
|---|
| 1334 | + | 17 |
|---|
| 1335 | + | 18 |
|---|
| 1336 | + | 19 |
|---|
| 1337 | + | 20 |
|---|
| 1338 | + | 21 |
|---|
| 1339 | + | 22 |
|---|
| 1340 | + | 23 |
|---|
| 1341 | + | 24 |
|---|
| 1342 | + | |
|---|
| 1343 | + | facility or by a purchaser of a product sold by or |
|---|
| 1344 | + | through the Oklahoma Tourism and Recreation |
|---|
| 1345 | + | Department, |
|---|
| 1346 | + | g. a Department of Defense Form 214 (DD Form 214) filed |
|---|
| 1347 | + | with a county clerk including any DD Form 214 filed |
|---|
| 1348 | + | before July 1, 2002, |
|---|
| 1349 | + | h. except as provided for in Section 2-110 of Title 47 of |
|---|
| 1350 | + | the Oklahoma Statutes, |
|---|
| 1351 | + | (1) any record in connection with a Motor Vehicle |
|---|
| 1352 | + | Report issued by the Department of Public Safety, |
|---|
| 1353 | + | as prescribed in Secti on 6-117 of Title 47 of the |
|---|
| 1354 | + | Oklahoma Statutes, or |
|---|
| 1355 | + | (2) personal information within driver records, as |
|---|
| 1356 | + | defined by the Driver ’s Privacy Protection Act, |
|---|
| 1357 | + | 18 United States Code, Sections 2721 through |
|---|
| 1358 | + | 2725, which are stored and maintained by the |
|---|
| 1359 | + | Department of Public Safety, or |
|---|
| 1360 | + | i. any portion of any document or information provided to |
|---|
| 1361 | + | an agency or entity of the state or a political |
|---|
| 1362 | + | subdivision to obtain licensure under the laws of this |
|---|
| 1363 | + | state or a political subdivision that contains an |
|---|
| 1364 | + | applicant’s personal address, personal phone number, |
|---|
| 1365 | + | personal electronic mail address or other contact |
|---|
| 1366 | + | information. Provided, however, lists of persons |
|---|
| 1367 | + | |
|---|
| 1368 | + | |
|---|
| 1369 | + | Req. No. 1217 Page 19 1 |
|---|
| 1370 | + | 2 |
|---|
| 1371 | + | 3 |
|---|
| 1372 | + | 4 |
|---|
| 1373 | + | 5 |
|---|
| 1374 | + | 6 |
|---|
| 1375 | + | 7 |
|---|
| 1376 | + | 8 |
|---|
| 1377 | + | 9 |
|---|
| 1378 | + | 10 |
|---|
| 1379 | + | 11 |
|---|
| 1380 | + | 12 |
|---|
| 1381 | + | 13 |
|---|
| 1382 | + | 14 |
|---|
| 1383 | + | 15 |
|---|
| 1384 | + | 16 |
|---|
| 1385 | + | 17 |
|---|
| 1386 | + | 18 |
|---|
| 1387 | + | 19 |
|---|
| 1388 | + | 20 |
|---|
| 1389 | + | 21 |
|---|
| 1390 | + | 22 |
|---|
| 1391 | + | 23 |
|---|
| 1392 | + | 24 |
|---|
| 1393 | + | 1 |
|---|
| 1394 | + | 2 |
|---|
| 1395 | + | 3 |
|---|
| 1396 | + | 4 |
|---|
| 1397 | + | 5 |
|---|
| 1398 | + | 6 |
|---|
| 1399 | + | 7 |
|---|
| 1400 | + | 8 |
|---|
| 1401 | + | 9 |
|---|
| 1402 | + | 10 |
|---|
| 1403 | + | 11 |
|---|
| 1404 | + | 12 |
|---|
| 1405 | + | 13 |
|---|
| 1406 | + | 14 |
|---|
| 1407 | + | 15 |
|---|
| 1408 | + | 16 |
|---|
| 1409 | + | 17 |
|---|
| 1410 | + | 18 |
|---|
| 1411 | + | 19 |
|---|
| 1412 | + | 20 |
|---|
| 1413 | + | 21 |
|---|
| 1414 | + | 22 |
|---|
| 1415 | + | 23 |
|---|
| 1416 | + | 24 |
|---|
| 1417 | + | |
|---|
| 1418 | + | licensed, the existence of a license of a per son, or a |
|---|
| 1419 | + | business or commercial address, or other business or |
|---|
| 1420 | + | commercial information disclosable under state law |
|---|
| 1421 | + | submitted with an application for licensure shall be |
|---|
| 1422 | + | public record, or |
|---|
| 1423 | + | j. information relating to prescription drugs as |
|---|
| 1424 | + | submitted by a reporting entity to the Insurance |
|---|
| 1425 | + | Department under this act; |
|---|
| 1426 | + | 2. “Public body” shall include, but not be limited to, any |
|---|
| 1427 | + | office, department, board, bureau, commission, agency, trusteeship, |
|---|
| 1428 | + | authority, council, committee, trust or any entity created by a |
|---|
| 1429 | + | trust, county, city, village, town, township, d istrict, school |
|---|
| 1430 | + | district, fair board, court, executive office, advisory group, task |
|---|
| 1431 | + | force, study group or any subdivision thereof, s upported in whole or |
|---|
| 1432 | + | in part by public fund s or entrusted with the expenditure of public |
|---|
| 1433 | + | funds or administering or operating public property, and all |
|---|
| 1434 | + | committees, or subcommittees thereof. Except for the records |
|---|
| 1435 | + | required by Section 24A.4 of this title, “public body” public body |
|---|
| 1436 | + | does not mean judges , justices, the Council on Judicia l Complaints, |
|---|
| 1437 | + | the Legislature or legislators. “Public body” Public body shall not |
|---|
| 1438 | + | include an organization that is exempt from federal income tax under |
|---|
| 1439 | + | Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, |
|---|
| 1440 | + | and whose sole beneficiary is a college or university, or an |
|---|
| 1441 | + | affiliated entity of the college or university, that is a member of |
|---|
| 1442 | + | |
|---|
| 1443 | + | |
|---|
| 1444 | + | Req. No. 1217 Page 20 1 |
|---|
| 1445 | + | 2 |
|---|
| 1446 | + | 3 |
|---|
| 1447 | + | 4 |
|---|
| 1448 | + | 5 |
|---|
| 1449 | + | 6 |
|---|
| 1450 | + | 7 |
|---|
| 1451 | + | 8 |
|---|
| 1452 | + | 9 |
|---|
| 1453 | + | 10 |
|---|
| 1454 | + | 11 |
|---|
| 1455 | + | 12 |
|---|
| 1456 | + | 13 |
|---|
| 1457 | + | 14 |
|---|
| 1458 | + | 15 |
|---|
| 1459 | + | 16 |
|---|
| 1460 | + | 17 |
|---|
| 1461 | + | 18 |
|---|
| 1462 | + | 19 |
|---|
| 1463 | + | 20 |
|---|
| 1464 | + | 21 |
|---|
| 1465 | + | 22 |
|---|
| 1466 | + | 23 |
|---|
| 1467 | + | 24 |
|---|
| 1468 | + | 1 |
|---|
| 1469 | + | 2 |
|---|
| 1470 | + | 3 |
|---|
| 1471 | + | 4 |
|---|
| 1472 | + | 5 |
|---|
| 1473 | + | 6 |
|---|
| 1474 | + | 7 |
|---|
| 1475 | + | 8 |
|---|
| 1476 | + | 9 |
|---|
| 1477 | + | 10 |
|---|
| 1478 | + | 11 |
|---|
| 1479 | + | 12 |
|---|
| 1480 | + | 13 |
|---|
| 1481 | + | 14 |
|---|
| 1482 | + | 15 |
|---|
| 1483 | + | 16 |
|---|
| 1484 | + | 17 |
|---|
| 1485 | + | 18 |
|---|
| 1486 | + | 19 |
|---|
| 1487 | + | 20 |
|---|
| 1488 | + | 21 |
|---|
| 1489 | + | 22 |
|---|
| 1490 | + | 23 |
|---|
| 1491 | + | 24 |
|---|
| 1492 | + | |
|---|
| 1493 | + | The Oklahoma State Sys tem of Higher Education . Such organization |
|---|
| 1494 | + | shall not receive di rect appropriations from the Oklahoma |
|---|
| 1495 | + | Legislature. The following persons shall not b e eligible to serve |
|---|
| 1496 | + | as a voting member of the governing bo ard of the organization: |
|---|
| 1497 | + | a. a member, officer, or employee of the Oklahoma State |
|---|
| 1498 | + | Regents for Higher Education , |
|---|
| 1499 | + | b. a member of the board of regents or other governing |
|---|
| 1500 | + | board of the college or university th at is the sole |
|---|
| 1501 | + | beneficiary of the organization, or |
|---|
| 1502 | + | c. an officer or employee of the college or university |
|---|
| 1503 | + | that is the sole beneficiary of the organizati on; |
|---|
| 1504 | + | 3. “Public office” means the physical lo cation where public |
|---|
| 1505 | + | bodies conduct business or keep record s; |
|---|
| 1506 | + | 4. “Public official” means any official or employee of any |
|---|
| 1507 | + | public body as defined herein; and |
|---|
| 1508 | + | 5. “Law enforcement agency” means any public body charged with |
|---|
| 1509 | + | enforcing state or local criminal laws and initiating criminal |
|---|
| 1510 | + | prosecutions including, but not limited to, police dep artments, |
|---|
| 1511 | + | county sheriffs, the Depar tment of Public Safety, the Oklahoma State |
|---|
| 1512 | + | Bureau of Narcotics and Dangerous Drugs Control, the Alcoholic |
|---|
| 1513 | + | Beverage Laws Enforcement Commi ssion, and the Oklahoma State Bureau |
|---|
| 1514 | + | of Investigation. |
|---|
| 1515 | + | |
|---|
| 1516 | + | |
|---|
| 1517 | + | |
|---|
| 1518 | + | |
|---|
| 1519 | + | Req. No. 1217 Page 21 1 |
|---|
| 1520 | + | 2 |
|---|
| 1521 | + | 3 |
|---|
| 1522 | + | 4 |
|---|
| 1523 | + | 5 |
|---|
| 1524 | + | 6 |
|---|
| 1525 | + | 7 |
|---|
| 1526 | + | 8 |
|---|
| 1527 | + | 9 |
|---|
| 1528 | + | 10 |
|---|
| 1529 | + | 11 |
|---|
| 1530 | + | 12 |
|---|
| 1531 | + | 13 |
|---|
| 1532 | + | 14 |
|---|
| 1533 | + | 15 |
|---|
| 1534 | + | 16 |
|---|
| 1535 | + | 17 |
|---|
| 1536 | + | 18 |
|---|
| 1537 | + | 19 |
|---|
| 1538 | + | 20 |
|---|
| 1539 | + | 21 |
|---|
| 1540 | + | 22 |
|---|
| 1541 | + | 23 |
|---|
| 1542 | + | 24 |
|---|
| 1543 | + | 1 |
|---|
| 1544 | + | 2 |
|---|
| 1545 | + | 3 |
|---|
| 1546 | + | 4 |
|---|
| 1547 | + | 5 |
|---|
| 1548 | + | 6 |
|---|
| 1549 | + | 7 |
|---|
| 1550 | + | 8 |
|---|
| 1551 | + | 9 |
|---|
| 1552 | + | 10 |
|---|
| 1553 | + | 11 |
|---|
| 1554 | + | 12 |
|---|
| 1555 | + | 13 |
|---|
| 1556 | + | 14 |
|---|
| 1557 | + | 15 |
|---|
| 1558 | + | 16 |
|---|
| 1559 | + | 17 |
|---|
| 1560 | + | 18 |
|---|
| 1561 | + | 19 |
|---|
| 1562 | + | 20 |
|---|
| 1563 | + | 21 |
|---|
| 1564 | + | 22 |
|---|
| 1565 | + | 23 |
|---|
| 1566 | + | 24 |
|---|
| 1567 | + | |
|---|
| 1568 | + | SECTION 10. This act shall become effective Nove mber 1, 2023. |
|---|
| 1569 | + | |
|---|
| 1570 | + | 59-1-1217 RD 1/18/2023 6:46:17 PM |
|---|